Stockscreener 앱 받기
1.12
2.61%
-0.03
Vivani Medical Inc 주식(VANI)의 최신 뉴스
Vivani Medical, Inc. (VANI) Stock Price Prediction for 2026, 2030-2040 - Traders Union
ClearOne expects October merger closing: what it means for ClearOne stock - AD HOC NEWS
Vivani Medical at H.C. Wainwright conference: implant pitch gains pace - investing.com
This Vivani Medical Insider Increased Their Holding By 17% Last Year - simplywall.st
Vivani Medical (NASDAQ:VANI) Trading Down 9.1%Here's What Happened - marketbeat.com
Maxim Group Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Vivani Medical to Participate in Upcoming Lake Street and H.C. Wainwright Investor Conferences - Quiver Quantitative
Two New York conferences are planned for Vivani Medical - Stock Titan
Vivani Medical Announces Participation in Upcoming Investor Conferences - GlobeNewswire
Outset Medical, Inc. (OM) Stock Price & News - Syfe
VANI Stock Price, Quote & Chart - ChartMill
Maxim Group Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $4 - moomoo.com
Vivani (VANI) Quarter in Review: EPS Lands Above Forecast in the Latest Session; Trading Response - Vinanet
Maxim Group Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Form 8K Vivani Medical Inc For: 17 August By Investing.com - Investing.com Nigeria
Form 8K Vivani Medical Inc For: 17 August By Investing.com - Investing.com Canada
Form 8K Vivani Medical Inc For: 17 August By Investing.com - Investing.com UK
Vivani Medical posts slide presentation under Reg FD; Exhibit 99.1 attached - TradingView
Vivani Medical posts investor deck outlining NanoPortal ultra-long-acting GLP-1 implant strategy for obesity market - Bitget
Wall Street Zen Upgrades Vivani Medical (NASDAQ:VANI) to "Hold" - MarketBeat
Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal - foreignpolicyjournal.com
VANI Q1 2026 Earnings: Narrower Loss Slightly Beats Consensus, Shares Rise 4.48%Balance Sheet Strength - vinanet.vn
Vivani Medical Fully Enrolls Phase 1 Semaglutide Implant Trial; Data Due November - Minichart
Form 8K Vivani Medical Inc For: 13 August By Investing.com - Investing.com Nigeria
Form 8K Vivani Medical Inc For: 13 August By Investing.com - Investing.com Australia
Vivani Medical (NASDAQ:VANI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Vivani Medical Q2 losses narrow 41% YoY; signs Novo Nordisk deal - scanx.trade
Vivani Medical: Q2 Earnings Snapshot - Barchart.com
Vivani Medical: Q2 Earnings Snapshot - KTVB
Form 8K Vivani Medical Inc For: 13 August By Investing.com - Investing.com India
Form 8K Vivani Medical Inc For: 13 August By Investing.com - Investing.com Canada
Form 8K Vivani Medical Inc For: 13 August By Investing.com - Investing.com UK
Vivani Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update - Yahoo Finance
Vivani Medical (VANI) widens GLP‑1 pipeline, funds runway into Q2 2027 - Stock Titan
ClearOne (CLRO) details Cortigent reverse merger, 78% Vivani control and new equity plan - Stock Titan
ClearOne to merge with Cortigent, pivoting to neurotech under new Nasdaq ticker - Dealroom
Vivani Medical Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
ClearOne Inc. (CLRO) majority holder cancels warrant as Cortigent merger proceeds - Stock Titan
Form 8K Vivani Medical Inc For: 6 August By Investing.com - Investing.com Nigeria
Vivani Medical Completes Enrollment, Dosing in Phase 1 SLIM-1 Trial - marketscreener.com
Why is ClearOne stock surging today? - Investing.com
Form 8K Vivani Medical Inc For: 6 August By Investing.com - Investing.com South Africa
Vivani Completes Enrollment in SLIM-1 Semaglutide Implant Trial - TipRanks
Form 8K Vivani Medical Inc For: 6 August - Investing.com India
Form 8K Vivani Medical Inc For: 6 August By Investing.com - Investing.com Canada
Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - The Manila Times
Semaglutide implant trial doses all 20 participants; data expected in November - Stock Titan
Top Midday Gainers - Yahoo Finance
Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - GlobeNewswire
4.22%
자본화:
|
볼륨(24시간):